115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation between disease-free survival endpoints and overall survival in elderly patients with early-stage HER2-negative breast cancer: A SEER-medicare analysis
    Journal Article

    Earla, J. R.; Kurian, A. W.; Kponee-Shovein, K.; Mahendran, M.; Song, Y.; Hua, Q.; Hilts, A.; Sun, Y.; Hirshfield, K. M.; Robson, M.; more...
    Advances in Therapy (2025)

    Fulltext@MSK | Save
  • WW vs TME in patients with rectal cancer with a complete or near-complete response to TNT: Pooled analysis of CAO/ARO/AIO-12 and OPRA trials
    Meeting Abstract

    Williams, H.; Fokas, E.; Diefenhardt, M.; Lin, S. T.; Qin, L. X.; Rodel, C.; Garcia-Aguilar, J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM)
    Meeting Abstract

    Fakih, M.; Segal, N. H.; Schlechter, B. L.; Andre, T.; Pietrantonio, F.; Johnson, B.; Vasilyev, A.; Krishnamurthi, S. S.; Siena, S.; Messersmith, W. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Shifting the paradigm: Early identification of colorectal cancer with C the Signs clinical decision support
    Meeting Abstract

    Dadhania, S.; Herrick, B.; Bakshi, B.; Raoof, S.; Haddad, T. C.; Patel, T.; Riaz, I. B.; Payling, M.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of patients (Pts) with metastatic colorectal cancer (mCRC) who received trifluridine-tipiracil (FTD-TPI) monotherapy or FTD-TPI + bevacizumab (FTD-TPI+bev) combination therapy
    Meeting Abstract

    Nusrat, M.; Zhao, R.; Khan, N.; Wang, Y.; Pierre-Victor, D.; Tepsick, J. G.; R, S.; Cann, C. G.; Salimi, T.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of trifluridine-tipiracil monotherapy (FTD-TPI) and FTD-TPI + bevacizumab combination therapy (FTD-TPI+bev) in 639 black patients (pts) with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Nusrat, M.; Zhao, R.; Khan, N.; Wang, Y.; Pierre-Victor, D.; Tepsick, J. G.; R, S.; Cann, C. G.; Salimi, T.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • The effect of anesthetic regimen on bone cement implantation syndrome in cemented hemiarthroplasty for hip fracture
    Journal Article

    Zastrow, R. K.; Rao, S. S.; Morris, C. D.; Levin, A. S.
    Journal of the American Academy of Orthopaedic Surgeons (2025)

    Fulltext@MSK | Save
  • Asymmetric background parenchymal enhancement on contrast-enhanced mammography: Associated factors, diagnostic workup, and clinical outcome
    Journal Article

    Nissan, N.; Gluskin, J.; Ochoa-Albiztegui, R. E.; Sung, J. S.; Jochelson, M. S.
    European Radiology (2025)

    Fulltext@MSK | Save
  • Are there features that can predict the unresectability of pleural mesothelioma?
    Journal Article

    Mayoral, M.; Araujo-Filho, J. A. B.; Tan, K. S.; Ortiz, E.; Adusumilli, P. S.; Rusch, V.; Zauderer, M.; Ginsberg, M. S.
    European Radiology (2025)

    Fulltext@MSK | Save
  • Association between geriatric co-management and receipt of rehabilitation services in the inpatient postoperative period among older adults with cancer
    Journal Article

    Bhurtyal, K. K.; Tin, A. L.; Vickers, A. J.; Shahrokni, A.
    Supportive Care in Cancer (2025)

    Fulltext@MSK | Save